OA09785A - Antiviral or antibacterial compound and method of use - Google Patents

Antiviral or antibacterial compound and method of use

Info

Publication number
OA09785A
OA09785A OA59731A OA59731A OA09785A OA 09785 A OA09785 A OA 09785A OA 59731 A OA59731 A OA 59731A OA 59731 A OA59731 A OA 59731A OA 09785 A OA09785 A OA 09785A
Authority
OA
OAPI
Prior art keywords
antiviral
composition
disclosed
antibacterial compound
forms
Prior art date
Application number
OA59731A
Other languages
English (en)
Inventor
Witold Kiczka
Original Assignee
Nika Health Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US07/459,738 priority Critical patent/US5200182A/en
Priority to RO143941A priority patent/RO110037B1/ro
Priority to PCT/US1988/001785 priority patent/WO1989011294A1/en
Priority to FI900412A priority patent/FI900412A0/fi
Priority to EP88905146A priority patent/EP0380484B1/de
Priority to SU884743095A priority patent/RU2092183C1/ru
Priority to AT88905146T priority patent/ATE93143T1/de
Priority to JP63504463A priority patent/JPH0649659B2/ja
Priority to AU19408/88A priority patent/AU624331B2/en
Priority to HU883981A priority patent/HU204710B/hu
Priority to CA000597341A priority patent/CA1335425C/en
Priority to IL9009289A priority patent/IL90092A/en
Priority to ZA893382A priority patent/ZA893382B/xx
Priority to ES8901637A priority patent/ES2011577A6/es
Priority to PH38684A priority patent/PH26284A/en
Priority to MA21811A priority patent/MA21560A1/fr
Priority to YU01092/89A priority patent/YU109289A/xx
Priority to CS893180A priority patent/CS277030B6/cs
Priority to DK199000168A priority patent/DK173078B1/da
Priority to MW3/90A priority patent/MW390A1/xx
Application filed by Nika Health Products Inc filed Critical Nika Health Products Inc
Priority to OA59731A priority patent/OA09785A/en
Priority to BG91270A priority patent/BG60544B1/bg
Priority to US07/865,002 priority patent/US5466449A/en
Priority to LVP-92-508A priority patent/LV10054B/en
Priority to SG24694A priority patent/SG24694G/en
Publication of OA09785A publication Critical patent/OA09785A/en
Priority to HK42394A priority patent/HK42394A/en
Priority to US08/474,663 priority patent/US6099835A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
OA59731A 1988-05-26 1990-01-26 Antiviral or antibacterial compound and method of use OA09785A (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
RO143941A RO110037B1 (ro) 1988-05-26 1988-05-26 Compoziții antivirale sau antibacteriene și metodă de tratare a infecțiilor, cu acestea
PCT/US1988/001785 WO1989011294A1 (en) 1988-05-26 1988-05-26 Antiviral or antibacterial compound and method of use
FI900412A FI900412A0 (fi) 1988-05-26 1988-05-26 Antiviral eller antibakteriell foerening och foerfarande foer anvaendning daerav.
EP88905146A EP0380484B1 (de) 1988-05-26 1988-05-26 Verwendung eines Lysozymdimeren und/oder Ribonucleasedimeren zur Herstellung eines antiviralen oder antibakteriellen Arzneimittels
SU884743095A RU2092183C1 (ru) 1988-05-26 1988-05-26 Антивирусный или антибактериальный состав и способ его употребления
US07/459,738 US5200182A (en) 1988-05-26 1988-05-26 Antiviral or antibacterial composition and method of use
AT88905146T ATE93143T1 (de) 1988-05-26 1988-05-26 Verwendung eines lysozymdimeren und/oder ribonucleasedimeren zur herstellung eines antiviralen oder antibakteriellen arzneimittels.
JP63504463A JPH0649659B2 (ja) 1988-05-26 1988-05-26 抗ウイルス及び抗菌組成物並びに使用方法
AU19408/88A AU624331B2 (en) 1988-05-26 1988-05-26 A composition having as its active ingredient lysozyme or ribonuclease dimer in a pharmaceutically acceptable carrier
HU883981A HU204710B (en) 1988-05-26 1988-05-26 Process for producing pharmaceutical compositions having antiviral and antibacterial effect
CA000597341A CA1335425C (en) 1988-05-26 1989-04-20 Antiviral or antibacterial compound and method of use
IL9009289A IL90092A (en) 1988-05-26 1989-04-27 Antiviral or antibacterial composition comprising a lysozyme dimer and/or a ribonuclease dimer and use thereof
ZA893382A ZA893382B (en) 1988-05-26 1989-05-08 Antiviral or antibacterial compound and method of use
ES8901637A ES2011577A6 (es) 1988-05-26 1989-05-16 Un procedimiento para preparar una composicion antiviral o antibacteriana mediante enzimas.
PH38684A PH26284A (en) 1988-05-26 1989-05-23 Antiviral or antibacterial composition and method of use thereof
MA21811A MA21560A1 (fr) 1988-05-26 1989-05-24 Nouvelles compositions comprenant des enzymes polymerises.
CS893180A CS277030B6 (en) 1988-05-26 1989-05-26 Antiviral and antibacterial agent
YU01092/89A YU109289A (en) 1988-05-26 1989-05-26 Process for obtaining anti-virus and anti-bacteria compound
MW3/90A MW390A1 (en) 1988-05-26 1990-01-22 Antiviral or antibacterial compound and method of use
DK199000168A DK173078B1 (da) 1988-05-26 1990-01-22 Anvendelse af en lysozym-dimer og/eller en ribonuclease-dimer til fremstilling af et lægemiddel til behandling af virus- el
OA59731A OA09785A (en) 1988-05-26 1990-01-26 Antiviral or antibacterial compound and method of use
BG91270A BG60544B1 (en) 1988-05-26 1990-02-22 Antiviral and antibacterial preparation and method for its usage
US07/865,002 US5466449A (en) 1988-05-26 1992-04-08 Antibacterial composition and method of use
LVP-92-508A LV10054B (en) 1988-05-26 1992-12-28 Antiviral or antibacterial compound and method of use
SG24694A SG24694G (en) 1988-05-26 1994-02-18 Use of lysozyme dimer and/or a ribonuclease dimer for the manufacture of an antiviral or antibiotic drug.
HK42394A HK42394A (en) 1988-05-26 1994-05-05 Use of a lysozyme dimer and/or a ribonuclease dimer for the manufacture of an antiviral or antibiotic drug
US08/474,663 US6099835A (en) 1988-05-26 1995-06-07 Method of using antiviral composition

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17858888A 1988-05-26 1988-05-26
PCT/US1988/001785 WO1989011294A1 (en) 1988-05-26 1988-05-26 Antiviral or antibacterial compound and method of use
OA59731A OA09785A (en) 1988-05-26 1990-01-26 Antiviral or antibacterial compound and method of use

Publications (1)

Publication Number Publication Date
OA09785A true OA09785A (en) 1994-04-15

Family

ID=33162813

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59731A OA09785A (en) 1988-05-26 1990-01-26 Antiviral or antibacterial compound and method of use

Country Status (23)

Country Link
US (3) US5200182A (de)
EP (1) EP0380484B1 (de)
JP (1) JPH0649659B2 (de)
AT (1) ATE93143T1 (de)
AU (1) AU624331B2 (de)
BG (1) BG60544B1 (de)
CA (1) CA1335425C (de)
CS (1) CS277030B6 (de)
DK (1) DK173078B1 (de)
ES (1) ES2011577A6 (de)
FI (1) FI900412A0 (de)
HK (1) HK42394A (de)
HU (1) HU204710B (de)
IL (1) IL90092A (de)
LV (1) LV10054B (de)
MA (1) MA21560A1 (de)
MW (1) MW390A1 (de)
OA (1) OA09785A (de)
PH (1) PH26284A (de)
RU (1) RU2092183C1 (de)
WO (1) WO1989011294A1 (de)
YU (1) YU109289A (de)
ZA (1) ZA893382B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0380484B1 (de) * 1988-05-26 1993-08-18 Nika Health Products Limited Verwendung eines Lysozymdimeren und/oder Ribonucleasedimeren zur Herstellung eines antiviralen oder antibakteriellen Arzneimittels
JP2732515B2 (ja) * 1990-01-08 1998-03-30 ニカ ヘルス プロダクツ リミテッド リボヌクレアーゼ二量体の製造方法
US5989880A (en) 1990-01-08 1999-11-23 Nika Health Products Ltd. Method of preparing lysozyme dimers
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
CH682541A5 (de) * 1992-06-23 1993-10-15 Urs Viktor Dr Wirth Biochemische Inaktivierung von RNA-Viren.
US6183742B1 (en) 1992-07-13 2001-02-06 Nika Health Products, Limited Applications of lysozyme dimer
DZ1964A1 (fr) * 1995-01-13 2002-10-15 Nika Health Products Ltd Nouvelle applications d'un dimère de lysozyme.
GB2304048A (en) * 1995-08-12 1997-03-12 John William Carson Medicament containing saliva extract
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
RU2157206C1 (ru) * 1999-03-10 2000-10-10 Оренбургская государственная медицинская академия Бактерицидный отогель
RU2172179C2 (ru) * 1999-06-24 2001-08-20 Сельков Сергей Алексеевич Шарики "биосан" для лечения кольпитов различного генеза и способ лечения кольпитов различного генеза
RU2191576C2 (ru) * 1999-07-27 2002-10-27 Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии Способ лечения субклинической формы генитальной герпесвирусной инфекции у женщин
RU2200550C2 (ru) * 1999-10-29 2003-03-20 Научно-исследовательская лаборатория иммунохимиотерапии лепры и иммунотропных средств с клиникой и опытно-экспериментальным производством Новые лекарственные формы димоцифона в терапии лепры, зудящих и аллергодерматозов, герпетиформного дерматита дюринга
RU2163119C1 (ru) * 2000-04-26 2001-02-20 Свистов Виталий Владимирович Антисептическое средство
RU2180593C1 (ru) * 2000-11-08 2002-03-20 Айламазян Эдуард Карпович Фармацевтическая композиция для лечения и профилактики генитального герпеса, хронической папилломы вирусной инфекции и профилактики рака шейки матки (варианты)
US6716813B2 (en) * 2000-11-28 2004-04-06 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
US7338936B2 (en) * 2000-11-28 2008-03-04 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
RU2177781C1 (ru) * 2000-12-06 2002-01-10 Научный Центр Здоровья детей РАМН Суппозитории ректальные, содержащие витаминный комплекс
JP2002187853A (ja) * 2000-12-21 2002-07-05 Shinei Ferumentekku:Kk 動物の乳頭除菌剤および菌環境改善方法
RU2195927C1 (ru) * 2001-07-13 2003-01-10 ООО "Тенториум" Абиес-свеча "канделла-два"
DE10210285A1 (de) * 2002-03-08 2003-11-13 Medigene Ag Reversibles Toxin und seine Verwendung
US8470315B2 (en) * 2004-04-13 2013-06-25 Quintessence Biosciences, Inc. Non-natural ribonuclease conjugates as cytotoxic agents
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
US7348301B2 (en) * 2006-02-16 2008-03-25 Buckman Laboratories International, Inc. Lysozyme-based method and composition to control the growth of microorganisms in aqueous systems
EP2044097A4 (de) * 2006-06-23 2010-10-06 Quintessence Biosciences Inc Modifizierte ribonukleasen
US8298801B2 (en) 2006-07-17 2012-10-30 Quintessence Biosciences, Inc. Methods and compositions for the treatment of cancer
RU2009136424A (ru) * 2007-03-02 2011-04-10 СЕНТ СИМЕОН ЭлДиЭй (US) Композиция и способ лечения папилломавируса и саркоидов лошадей
WO2009036000A2 (en) * 2007-09-11 2009-03-19 University Of Maryland, Baltimore Methods of treating a microbial infection by modulating rnase-l expression and/or activity
JP2010540681A (ja) * 2007-10-08 2010-12-24 クインテッセンス バイオサイエンシズ，インコーポレーテッド リボヌクレアーゼに基づく治療のための組成物及び方法
US8029782B2 (en) 2008-10-01 2011-10-04 Quintessence Biosciences, Inc. Therapeutic ribonucleases
US20100215707A1 (en) * 2009-02-25 2010-08-26 Mcdonald Thomas Activated creatinine and precursors thereof as antibacterial agents, compositions and products containing such agents and uses thereof
NZ600269A (en) 2009-05-20 2014-02-28 Dec Int Nz Ltd Delivery device for treatment of mastitis
PL2457576T3 (pl) 2010-11-29 2021-04-06 Eurochit Danuta Kruszewska Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji
RU2548803C2 (ru) * 2011-11-28 2015-04-20 Общество с ограниченной ответственностью " Фарматренд" ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ ГЛАЗНЫХ ИНФЕКЦИЙ P. Aeruginosa, СОДЕРЖАЩАЯ РЕКОМБИНАНТНЫЙ ЛИЗОЦИМ
RU2509801C2 (ru) * 2012-03-22 2014-03-20 Борис Михайлович Куриненко СПОСОБ ИСПОЛЬЗОВАНИЯ РИБОНУКЛЕАЗЫ Bacillus intermedius
KR20150027152A (ko) 2012-05-29 2015-03-11 다누타 크루셰프스카 인간 및 동물 모두에서 예방 및 의약에 유용한 락토바실러스 류테리 ｄａｎ080을 포함하는 나노프로덕트 및 이의 의학적 용도
EP2674162A1 (de) 2012-05-29 2013-12-18 Danuta Kruszewska Nanoprodukt, beinhaltend lactobacillus reuteri dan080, zur verwendung bei der prophylaxe, diagnose sowie bei der medizinischen and veterinärmedizinischen behandlung
RU2504397C1 (ru) * 2012-10-25 2014-01-20 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая фермент рибонуклеазу и глицирризиновую кислоту или ее соли: глицирризинат аммония, или дикалия, или тринатрия
US9573980B2 (en) 2013-03-15 2017-02-21 Spogen Biotech Inc. Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Bacillus spores on plant roots
US9950075B2 (en) 2013-03-15 2018-04-24 The University Of Massachusetts Compositions and methods for delivering agents to the central nervous system
WO2015125961A1 (ja) * 2014-02-21 2015-08-27 国立大学法人東京海洋大学 ノロウィルス不活化剤及びその製造方法、ノロウィルス不活化方法、ノロウィルス不活化用リゾチーム類の製造方法、ノロウィルス感染の予防薬又は治療薬、並びにノロウィルス不活化用皮膚外用剤
WO2016017784A1 (ja) * 2014-07-31 2016-02-04 キユーピー株式会社 含水流動状組成物及びその製造方法、並びに、リゾチーム加工品及び／又はその塩並びにその製造方法
IL315468A (en) 2014-09-17 2024-11-01 Spogen Biotech Inc Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria
LV15071B (lv) * 2015-07-14 2016-02-20 Rīgas Stradiņa Universitāte Kompozīcija subklīniska mastīta ārstēšanai govīm
RU2634264C1 (ru) * 2016-09-19 2017-10-24 Александр Ливиевич Ураков Крем-молочко для лечения опоясывающего лишая
CN110088650B (zh) 2016-12-28 2021-09-07 Dic株式会社 分散体和使用其的喷墨用油墨组合物、光转换层、和液晶显示元件
WO2019060574A1 (en) 2017-09-20 2019-03-28 Spogen Biotech Inc. FUSION PROTEINS, RECOMBINANT BACTERIA AND EXIN FRAGMENTS FOR PLANT HEALTH
WO2021021765A1 (en) * 2019-07-26 2021-02-04 Evolve Biosystems, Inc. Nutritive compositions with bioactive proteins

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1268M (fr) * 1961-06-29 1962-04-24 Puiseux Médicament antimitotique et antiviral.
FR4020M (de) * 1965-01-29 1966-03-21
DE1517751C3 (de) * 1965-07-08 1975-02-27 Eisai Co., Ltd., Tokio Verfahren zum Verhindern der Bildung von flockigen Lysozym- und/oder Lysozymsalzniederschlägen in wässrigen Lösungen, die Lysozym und/oder Lysozymsalze enthalten
DE1545644A1 (de) * 1965-12-06 1969-08-07 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen quaternaeren Scopolammoniumsalzen
GB1110504A (en) * 1966-03-18 1968-04-18 Prodotti Antibiotici Spa Pharmaceutical compositions
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity
US4510144A (en) * 1981-08-26 1985-04-09 Newport Pharmaceuticals International Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives
CA1263378A (en) * 1985-01-08 1989-11-28 Robert James Alaimo Imidazo¬4,5-f|quinolines useful as immunomodulating agents
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
EP0380484B1 (de) * 1988-05-26 1993-08-18 Nika Health Products Limited Verwendung eines Lysozymdimeren und/oder Ribonucleasedimeren zur Herstellung eines antiviralen oder antibakteriellen Arzneimittels

Also Published As

Publication number Publication date
HU883981D0 (en) 1990-12-28
IL90092A (en) 1995-03-30
BG91270A (bg) 1993-12-24
RU2092183C1 (ru) 1997-10-10
LV10054A (lv) 1994-05-10
ATE93143T1 (de) 1993-09-15
MW390A1 (en) 1990-11-14
WO1989011294A1 (en) 1989-11-30
US5200182A (en) 1993-04-06
PH26284A (en) 1992-04-10
EP0380484A1 (de) 1990-08-08
HK42394A (en) 1994-05-13
FI900412A7 (fi) 1990-01-25
CS318089A3 (en) 1992-05-13
BG60544B1 (en) 1995-08-28
CA1335425C (en) 1995-05-02
FI900412A0 (fi) 1990-01-25
YU109289A (en) 1991-08-31
DK173078B1 (da) 1999-12-20
JPH03504121A (ja) 1991-09-12
EP0380484B1 (de) 1993-08-18
LV10054B (en) 1995-02-20
HUT54060A (en) 1991-01-28
DK16890A (da) 1990-01-22
MA21560A1 (fr) 1989-12-31
ZA893382B (en) 1991-01-30
AU624331B2 (en) 1992-06-11
HU204710B (en) 1992-02-28
ES2011577A6 (es) 1990-01-16
US5466449A (en) 1995-11-14
DK16890D0 (da) 1990-01-22
JPH0649659B2 (ja) 1994-06-29
CS277030B6 (en) 1992-11-18
US6099835A (en) 2000-08-08
AU1940888A (en) 1989-12-12

Similar Documents

Publication Publication Date Title
MW390A1 (en) Antiviral or antibacterial compound and method of use
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
MX9702932A (es) L-ribofuranosilnucleosidos.
AU7211787A (en) Intraocular dosage compositions and method of use
AU5287090A (en) Method and composition for treatment of periodontal disease
IL84510A (en) Agents for combating pests and plant treatment agents consisting of microorganism granulates
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
ZA898605B (en) Compositions for topical treatment of skin diseases
JO1610B1 (en) Tetrahydimidimidose compounds (1,4) benzodiazepine-2 thyonath anti-viral and anti-viral
JO1589B1 (en) Ketones (quaternary hydroimidazo (4.1) benzo-diazepine-2) anti-viral
ZA929947B (en) Method of imparting antimicrobial activity to an opthalmic composition.
EP0813409A4 (de) Behandlung von erkrankungen, die vom cytokinwachstumsfaktor verursacht werden
WO1999024077A3 (en) Compositions and methods for targeted delivery of biologically-active factors
AU2840889A (en) Method of treating haematologic diseases and pharmaceutical compositions to be used therefor
HUT50844A (en) Process for producing new 2'-halogen methylidene, 2'-ethenylidene and 2'-ethinyladenosine derivatives and pharmaceutical compositions comprising same as active ingredient
GEP20012511B (en) Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis
MY106984A (en) Antiviral or antibacterial composition and method of use.
AU591017B2 (en) Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient
GEP19971029B (en) Antiviral or antibacterial compound and method of use thereof
AU3575189A (en) Long lasting composition of propafenone and quinidine for treatment of cardiac conditions
GR1001006B (el) Μεθοδος παρασκευης και χρησιμοποιησεως αντιιικων η αντιβακτηριακων συνθεσεων.
CA2097878A1 (en) Therapeutic agent for neutropenia
EP0491873A4 (en) Therapeutic compositions; methods for treatment of hiv infections
AU2314488A (en) Anthelmintic acylhydrazones, method of use and compositions
MX9307639A (es) Metodo para tratar infecciones virales con terapia conjuntiva con compuestos similares al aciclovir y un analogo de nucleosido 2'-viril substituido.